|
US4443340A
(en)
|
1981-10-09 |
1984-04-17 |
Betz Laboratories, Inc. |
Control of iron induced fouling in water systems
|
|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
JPH04230389A
(ja)
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
IL102414A
(en)
|
1991-07-25 |
1996-08-04 |
Univ Louisville Res Found |
Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
|
|
FI933471A0
(fi)
|
1991-12-19 |
1993-08-05 |
Mitsui Toatsu Chemicals |
Polyhydroxikarboxylsyra och foerfarande foer dess framstaellning
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
US5242910A
(en)
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
DE69634277T2
(de)
*
|
1995-06-07 |
2006-01-05 |
Southern Biosystems, Inc., Birmingham |
Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
|
DE60231862D1
(de)
|
2001-02-23 |
2009-05-20 |
Genentech Inc |
Erodierbare polymere zur injektion
|
|
WO2004011054A2
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
|
ES2428354T3
(es)
|
2002-09-18 |
2013-11-07 |
Trustees Of The University Of Pennsylvania |
Rapamicina para usar en la inhibición o prevención de la neovascularización coroidea
|
|
MXPA05004927A
(es)
|
2002-11-06 |
2005-09-08 |
Alza Corp |
Formulaciones de deposito de liberacion controlada.
|
|
ATE482695T1
(de)
|
2002-12-13 |
2010-10-15 |
Durect Corp |
Orale darreichungsform mit flüssigen hochviskosen trägersystemen
|
|
WO2004081196A2
(en)
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
|
JP2007505932A
(ja)
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
BRPI0515372B8
(pt)
*
|
2004-09-17 |
2021-05-25 |
Durect Corp |
composição líquida para fornecer anestesia local prolongada após administração a um indivíduo, e, uso de bupivacaína, acetato isobutirato de sacarose e álcool benzílico
|
|
EP3173072A1
(en)
|
2004-10-01 |
2017-05-31 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2006086750A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Liquid formulations for treatment of diseases or conditions
|
|
JP2008533204A
(ja)
*
|
2005-03-21 |
2008-08-21 |
マクサイト， インコーポレイテッド |
病気又は症状の治療のためのドラッグ送達システム
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
US8492400B2
(en)
|
2006-02-09 |
2013-07-23 |
Santen Pharmaceutical Co., Ltd. |
Stable formulations, and methods of their preparation and use
|
|
CN101443004B
(zh)
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂
|
|
CN1973822A
(zh)
|
2006-12-20 |
2007-06-06 |
山东蓝金生物工程有限公司 |
一种含雷帕霉素的抗癌组合物
|
|
US20100184659A1
(en)
|
2006-12-21 |
2010-07-22 |
Warren Jaworowicz |
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
|
|
WO2008143992A2
(en)
|
2007-05-18 |
2008-11-27 |
Durect Corporation |
Improved depot formulations
|
|
WO2009023877A2
(en)
*
|
2007-08-16 |
2009-02-19 |
Macusight, Inc. |
Formulations for treatment of ocular diseases or conditions
|
|
WO2009075782A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
|
CN102131483A
(zh)
*
|
2008-02-08 |
2011-07-20 |
昌达生物科技公司 |
可控给药非聚合组合物
|
|
EP2427174A4
(en)
|
2009-05-04 |
2014-01-15 |
Santen Pharmaceutical Co Ltd |
HEMMER OF THE MTOR SIGNAL PATH FOR THE TREATMENT OF EYE TROUBLE
|
|
EP2643009A4
(en)
|
2010-11-24 |
2015-04-01 |
Durect Corp |
COMPOSITION FOR THE RELEASE OF BIODEGRADABLE ACTIVE SUBSTANCES
|
|
EP2782590A4
(en)
|
2011-11-23 |
2016-08-03 |
Durect Corp |
BIODEGRADABLE AND MEDIUM-RADIATED STERILIZED MEDICAMENTAL COMPOSITIONS
|
|
RU2672596C2
(ru)
|
2012-01-23 |
2018-11-16 |
Аллерган, Инк. |
Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
|
|
EP2986278A1
(en)
*
|
2013-03-11 |
2016-02-24 |
DURECT Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
|
EP2970253A4
(en)
|
2013-03-15 |
2016-11-02 |
Durect Corp |
COMPOSITIONS WITH THIXOTROPY AND IMPROVED RESOLUTION REPRODUCIBILITY AND STABILITY
|
|
CA2905131A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
EP4082525A1
(en)
|
2013-05-24 |
2022-11-02 |
Icon Bioscience, Inc. |
Use of sustained release dexamethasone in post-cataract surgery inflammation
|
|
WO2016079330A1
(en)
|
2014-11-21 |
2016-05-26 |
Technical University Of Denmark |
Gel formulations for local drug release
|
|
CN107427587A
(zh)
|
2015-03-18 |
2017-12-01 |
参天制药株式会社 |
缓释性医药组合物
|
|
AR105215A1
(es)
|
2015-07-01 |
2017-09-13 |
Santen Pharmaceutical Co Ltd |
Formulación de depósito que contiene ésteres de ácido cítrico
|
|
US10668011B2
(en)
|
2016-06-30 |
2020-06-02 |
Durect Corporation |
Depot formulations
|
|
ES2944576T3
(es)
|
2017-01-06 |
2023-06-22 |
Santen Pharmaceutical Co Ltd |
Administración intratumoral de sirólimus para el tratamiento del cáncer de próstata
|